Mostrar el registro sencillo del ítem

dc.rights.licenseopenen_US
dc.contributor.authorLOFFLER, A.
dc.contributor.authorVENIER, Anne-Gaelle
dc.contributor.authorJOUZEAU, A.
dc.contributor.authorPEFAU, M.
dc.contributor.authorDUGRAVOT, L.
dc.contributor.authorCHABAUD, A.
dc.contributor.authorSIMON, L.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDUMARTIN, Catherine
dc.date.accessioned2023-02-17T08:53:26Z
dc.date.available2023-02-17T08:53:26Z
dc.date.issued2022-12-08
dc.identifier.issn2666-9919 (Electronic) 2666-9919 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/171977
dc.description.abstractEnOBJECTIVES: This study aimed to investigate factors associated with daptomycin consumption in French healthcare facilities (HCF) between 2019 and 2020. METHODS: Antibiotic consumption expressed as number of defined daily doses (DDD) per 1,000 patient-days (PD) and antimicrobial resistance (AMR) expressed as incidence densities per 1,000PD were extracted each year from the nationwide surveillance network run by the SPARES project (Surveillance and Prevention of Antimicrobial RESistance in hospitals), collecting data at ward level among voluntary HCFs using standardized methodology and webtool. All HCF participating both in 2019 and 2020 were included. A multivariable linear regression was fitted. RESULTS: Among 622 HCFs, we analyzed daptomycin consumption and AMR data in 1,637 clinical wards. Incidence densities of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant coagulase-negative staphylococci (MRCNS) were the highest in intensive care unit wards (0.54 and 6.83 respectively in 2020). On the best adjusted model, the year 2020 was correlated with a higher daptomycin consumption (1.53; p=0.01). A greater number of inpatient beds (0.01; p<0.001), the presence of orthopedic surgery activity in the HCF (1.66; p<0.02), MRSA (4.38; p<0.001) and MRCNS (0.61; p<0.001) incidence densities were associated with a higher daptomycin use. The final model explained 18% of the observed variance. CONCLUSIONS: This study showed that daptomycin consumption was correlated to MRSA and MRCNS incidence densities, to the year 2020 and to non-modifiable HCF-related factors. Prevention of coagulase-negative staphylococci infections should be considered by antimicrobial stewardship teams when daptomycin use is going up in HCF.
dc.language.isoENen_US
dc.subject.enDaptomycin
dc.subject.enAntimicrobial resistance
dc.subject.enAntibiotic consumption
dc.subject.enStaphylococcus aureus
dc.subject.enCoagulase-negative staphylococcus
dc.title.enFactors associated with daptomycin consumption in French hospitals between 2019 and 2020: a nationwide surveillance study
dc.title.alternativeInfect Dis Nowen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.idnow.2022.12.001en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed36503170en_US
bordeaux.journalInfectious Diseases Nowen_US
bordeaux.volume52en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue2en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamAHEAD_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03993691
hal.version1
hal.date.transferred2023-02-17T08:53:29Z
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.jtitle=Infectious%20Diseases%20Now&amp;rft.date=2022-12-08&amp;rft.volume=52&amp;rft.issue=2&amp;rft.eissn=2666-9919%20(Electronic)%202666-9919%20(Linking)&amp;rft.issn=2666-9919%20(Electronic)%202666-9919%20(Linking)&amp;rft.au=LOFFLER,%20A.&amp;VENIER,%20Anne-Gaelle&amp;JOUZEAU,%20A.&amp;PEFAU,%20M.&amp;DUGRAVOT,%20L.&amp;rft.genre=article


Archivos en el ítem

ArchivosTamañoFormatoVer

No hay archivos asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem